Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Brian Nicholson, Smita Patel, Nicola Sibson and their collaborators who have been awarded funding in the inaugural round of the OxCODE Funding Scheme.

The Oxford Centre for Early Cancer Detection (OxCODE) Funding Scheme was launched in May 2020 with a call for proposals that would advance innovative Oxford-based research that can be applied to detecting cancer earlier. OxCODE aims to pump-prime this activity by providing short-term awards that will enable the development of proof-of-concept projects, technologies, assays and platforms to a stage at which more long-term external funding can be sought. Priority was given to projects with a clear translational trajectory towards the ultimate longer-term goal of improving cancer patient care through earlier detection.

After peer review by the OxCODE Funding Scheme 2020 review group, the OxCODE Management Committee allocated funds to the following projects:

  • Dr Brian Nicholson (Nuffield Department of Primary Care Health Sciences) “Enhancing non-invasive patient stratification for endoscopic detection of colorectal cancer in response to the COVID-19 pandemic”
  • Dr Smita Patel (Experimental Medicine Division, Nuffield Department of Medicine) “Methylation, malignancy and primary immunodeficiency: early detection of pre-malignant changes and sub-clinical disease”
  • Professor Nicola Sibson (Department of Oncology) “Biofluid metabolomics for detection of cancer in patients with non-specific signs”

Congratulations to these teams and thank you to all applicants for their submissions.

Similar stories

Blood tests provide no additional information to FIT alone when prioritising patients for colorectal cancer referral

Faecal immunochemical testing (FIT) alone leads to the identification of the same number of patients with colorectal cancer as more complicated approaches that combine the FIT result with the results of commonly used blood tests.

New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.